Cargando…
T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
In cancer, non-synonymous DNA base changes alter protein sequence and produce neoantigens that are detected by the immune system. For immune detection, neoantigens must first be presented on class I or II human leukocyte antigens (HLA) followed by recognition by peptide-specific receptors, exemplifi...
Autores principales: | Sim, Malcolm J. W., Sun, Peter D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867076/ https://www.ncbi.nlm.nih.gov/pubmed/35222422 http://dx.doi.org/10.3389/fimmu.2022.833017 |
Ejemplares similares
-
Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021) -
The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
por: Karpanen, Terhi, et al.
Publicado: (2017) -
Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019) -
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2018) -
Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)